BiotechTube
Home/Tvardi Therapeutics/Keith T. Flaherty, M.D.
KT

Keith T. Flaherty, M.D.

Scientific Advisory Board Member

Tvardi Therapeutics

Therapeutic Areas

FibrosisOncologyInflammatory Diseases

Tvardi Therapeutics Pipeline

DrugIndicationPhase
TTI-101Idiopathic Pulmonary Fibrosis (IPF)Phase 2
TTI-102Undisclosed Inflammatory/FibroticPreclinical
Korsuva (difelikefalin)Chronic Kidney Disease-Associated Pruritus (CKD-aP)Marketed
Oral KorsuvaNotalgia Paresthetica & CKD-aPPhase 2/3

Leadership Team at Tvardi Therapeutics

IA
Imran Alibhai, Ph.D.
Chief Executive Officer
RA
Ronald A. DePinho, M.D.
Co-Founder and Director
DJ
David J. Tweardy, M.D.
Co-Founder and Chief Scientific Officer
MJ
Michael J. Lewis, Ph.D.
Co-Founder
View full Tvardi Therapeutics profile